By Alyse Stach (The Antitrust Advocate)
As many businesses look for solutions to weather the economic impact of the COVID-19 pandemic, one potential avenue for distressed companies is to seek to be acquired by a more stable firm looking to expand.
The antitrust regulators have made clear that all types of mergers – even during a global crisis – will be subject to ordinary antitrust scrutiny. As those principles are applied, merging companies may look more frequently to the “failing firm” defense to convince regulators that their deal should pass regulatory hurdles when it otherwise might not.
However, the requirements for meeting the failing firm standard are high, and merging parties should not assume that financial struggles during the pandemic will provide a free pass through merger review…
Featured News
Major Defence Contractors Accused of Price-Fixing in Multibillion-Dollar Scandal
Dec 15, 2024 by
CPI
Meta Urges California Attorney General to Block OpenAI’s Move to For-Profit Status
Dec 15, 2024 by
CPI
Coinbase Faces $1 Billion Lawsuit Over Wrapped Bitcoin Delisting
Dec 15, 2024 by
CPI
House Republicans Investigate CVS Caremark Over Alleged Antitrust Violations
Dec 15, 2024 by
CPI
Turkey Fines Google $75 Million for Antitrust Violations in Ad Services
Dec 15, 2024 by
CPI
Antitrust Mix by CPI
Coopetition in The Pharma Industry: Challenges for Antitrust
Dec 12, 2024 by
Juan Delgado & Lourdes Sosa
Symmetry and the Sixth Force: The Essential Role of Complements
Dec 12, 2024 by
Adam Brandenburger & Barry Nalebuff
ESG Collaborations in Light of European Antitrust Policy and Enforcement Trends
Dec 12, 2024 by
Christian Ritz, Julia Gingelmaier & Kyra Harmes
Antitrust Chronicle® – Co-opetition
Dec 11, 2024 by
CPI
Antitrust Chronicle® – Moats & Entrenchment
Nov 29, 2024 by
CPI